Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
Bristol Myers (BMY) Reports Q4 Earnings: What Key Metrics Have to Say
10:32am, Thursday, 05'th Feb 2026
Although the revenue and EPS for Bristol Myers (BMY) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall
Bristol Myers Flags Data-Rich 2026 After Solid Quarter
10:07am, Thursday, 05'th Feb 2026
Bristol Myers Squibb & Co. (NYSE: BMY) reported fourth-quarter 2025 revenues of $12.50 billion on Thursday, beating the consensus of $12.281 billion, a 1% increase year over year.
Bristol Myers Squibb (BMY) Tops Q4 Earnings and Revenue Estimates
09:11am, Thursday, 05'th Feb 2026
Bristol Myers Squibb (BMY) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.15 per share. This compares to earnings of $1.67 per share a year ago.
First Look: AI shock hits software, Bitcoin breaks $70K, Disney names new CEO
07:38am, Thursday, 05'th Feb 2026
Stock News Bezos backs Post amid sweeping cuts: Amazon (AMZN) founder Jeff Bezos' Washington Post slashed roughly a third of staff and eliminated its Sports dep
Bristol Myers Stock Rises. Why Fourth-Quarter Earnings Are Exciting Investors.
07:17am, Thursday, 05'th Feb 2026
Bristol Myers Squibb issues an especially upbeat outlook for 2026.
Bristol Myers Squibb Revenue Ticks Up on Immuno-Oncology Growth
07:09am, Thursday, 05'th Feb 2026
Bristol Myers Squibb reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for some of its older drugs.
Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off
07:01am, Thursday, 05'th Feb 2026
Bristol Myers Squibb on Thursday forecast 2026 results above Wall Street estimates, saying that price cuts to its blood thinner Eliquis will help drive up revenue.
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025
06:59am, Thursday, 05'th Feb 2026
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025.
Market Today: Tech Slump, Google AI Spend, Bitcoin Slide
05:35pm, Wednesday, 04'th Feb 2026
Guru Stock PicksAzvalor Internacional FI has made the following transactions:Reduce in XMAD: PSG by 98.37%Sold out in BAAdd in XMAD: COL by 6.77%New position in A
OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers Squibb
07:00am, Wednesday, 04'th Feb 2026
Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has expanded its strategic partnership with Bristol Myers Squibb (�
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi
06:59am, Wednesday, 04'th Feb 2026
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi.
Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?
12:40pm, Tuesday, 03'rd Feb 2026
BMY leans on fast-growing Reblozyl, now a $2B+ franchise, to fuel results as generics pressure legacy drugs ahead of Q4 earnings.
Bristol Myers Squibb Introduces "Change the Target. Change What's Possible.
06:59am, Tuesday, 03'rd Feb 2026
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #FXIa--Bristol Myers Squibb Introduces "Change the Target. Change What's Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care.
Bristol Myers Squibb Company $BMY Shares Sold by Pettee Investors Inc.
05:18am, Tuesday, 03'rd Feb 2026
Pettee Investors Inc. trimmed its holdings in shares of Bristol Myers Squibb Company (NYSE: BMY) by 63.1% in the third quarter, according to the company in its most recent filing with the Securities a
Peterson Wealth Services Buys 41,762 Shares of Bristol Myers Squibb Company $BMY
04:40am, Tuesday, 03'rd Feb 2026
Peterson Wealth Services increased its position in Bristol Myers Squibb Company (NYSE: BMY) by 4,167.9% in the undefined quarter, according to the company in its most recent 13F filing with the Securi
